Cisatracurium Besylate Injection

Dosage form: injection, solution
Drug class:Neuromuscular blocking agents

Medically reviewed by Drugs.com. Last updated on Jan 1, 2022.

Indications and Usage for Cisatracurium Besylate Injection

Cisatracurium Besylate Injection, USP is indicated:

•as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age

•to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the ICU

•to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older

Limitations of Use

Cisatracurium Besylate Injection, USP is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action.

DOSAGE & ADMINISTRATION

Important Dosage and Administration Instructions

Important administration instructions include:

• Cisatracurium Besylate Injection, USP is for intravenous use only.
• Administer Cisatracurium besylate injection, USP in carefully adjusted dosage by or under the supervision of experienced clinicians who are familiar with the drug’s actions and the possible complications.
• Use Cisatracurium besylate injection, USP only if the following are immediately available: personnel and facilities for resuscitation and life support (tracheal intubation, artificial ventilation, oxygen therapy); and an antagonist of Cisatracurium besylate injection, USP [see Overdosage (10)].
• The dosage information which follows is intended to serve as an initial guide for individual patients; base subsequent Cisatracurium besylate injection, USP dosage on the patients’ responses to the initial doses.
• Use a peripheral nerve stimulator to:

◦ Determine the adequacy of neuromuscular blockade (e.g., need for additional Cisatracurium besylate injection, USP doses, reduction of the infusion...